These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 37791037
21. Glucagon-like peptide 1 and glucose-dependent insulinotropic peptide hormones and novel receptor agonists protect synapses in Alzheimer's and Parkinson's diseases. Hölscher C. Front Synaptic Neurosci; 2022; 14():955258. PubMed ID: 35965783 [Abstract] [Full Text] [Related]
22. A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease. Jalewa J, Sharma MK, Gengler S, Hölscher C. Neuropharmacology; 2017 May 01; 117():238-248. PubMed ID: 28223210 [Abstract] [Full Text] [Related]
24. Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease. Rauschenberger L, Behnke J, Grotemeyer A, Knorr S, Volkmann J, Ip CW. Neurobiol Dis; 2022 Sep 01; 171():105798. PubMed ID: 35750147 [Abstract] [Full Text] [Related]
25. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease. Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, Volkmann J, Koprich JB. Acta Neuropathol Commun; 2017 Feb 01; 5(1):11. PubMed ID: 28143577 [Abstract] [Full Text] [Related]
36. Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice. Wu Q, Yang X, Zhang Y, Zhang L, Feng L. Exp Neurol; 2016 Nov 04; 285(Pt A):61-71. PubMed ID: 27637804 [Abstract] [Full Text] [Related]
37. Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases. Hölscher C. J Endocrinol; 2014 Apr 04; 221(1):T31-41. PubMed ID: 23999914 [Abstract] [Full Text] [Related]
39. Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases. Hölscher C. Sheng Li Xue Bao; 2014 Oct 25; 66(5):497-510. PubMed ID: 25331995 [Abstract] [Full Text] [Related]